Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
AffaMed Therapeutics Announces the Establishment of AffaMed Digital to Advance Digital Medicines 2021-11-10 15:00
OMRON Launches World's Fastest CT X-ray Inspection with New VT-X750-V3 AXI System 2021-11-10 14:00
Bon Natural Life Limited Announces Corporate Reorganization and Removal of VIE Structure 2021-11-09 22:00
I-Mab and ABL Bio Report Preclinical Data of 4-1BB-targeting Bispecific Antibodies at 2021 SITC 2021-11-09 21:05
Alterity Therapeutics Announces Presentation of ATH434 at the American Autonomic Society Virtual Meeting 2021 2021-11-09 20:30
FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer 2021-11-09 19:00
InnoRNA of China participates in the Hanmi Science Consortium …"To join forces to eliminate 'vaccine divide'" 2021-11-09 14:20
InnoCare to Present Orelabrutinib Data at the Upcoming 63rd Annual Meeting of ASH 2021-11-09 13:06
Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery 2021-11-09 10:47
BIORCHESTRA will present data on the therapeutic efficacy of their proprietary ASO against pathological miRNA, a key modulator of neuroinflammation and neurodegeneration, at the CTAD Meeting in Boston 2021-11-08 22:59
Ascentage Pharma Announces Clinical Trial Agreement to Evaluate the Combination of Lisaftoclax (APG-2575) and the CDK4/6 Inhibitor IBRANCE® (Palbociclib) in Metastatic ER+/HER2- Breast Cancer 2021-11-08 21:47
VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business Update 2021-11-08 21:30
I-Mab and Roche Diagnostics Announce Strategic Collaboration to Co-Develop Companion Diagnostics Solutions for I-Mab's Innovative Pipeline at the 4th CIIE 2021-11-08 21:00
Farmmi Announces Latest Multi-Product Sales Win 2021-11-08 21:00
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program 2021-11-08 08:10
PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline 2021-11-05 20:37
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases 2021-11-05 14:57
ASH 2021 | Ascentage Pharma to Release Latest Data from Two Studies of Its Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a Chinese Study Demonstrating Complete Response 2021-11-05 09:05
ASH 2021 | Ascentage Pharma to Present Three Studies of Olverembatinib (HQP1351), a Novel Drug Candidate for the Treatment of Drug-Resistant Leukemia, in Abstracts Including One Oral Report at ASH Annual Meeting 2021-11-05 08:43
Lunit to Participate in RSNA 2021, Presenting its New AI Solutions for Digital Breast Tomosynthesis and Chest CT 2021-11-04 23:00
1 191 192 193 194 195 802